Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differences in rhodamine-123 efflux in B-type chronic lymphocytic leukemia suggest possible gender and stage variations in drug-resistance gene activity.

Annals of hematology - 1 May 1998

Steiner H, Polliack A, Kimchi-Sarfaty C, Libster D, Fibach E, Rund D

Abstract excerpt

Peripheral blood samples from 61 patients (36 male, 25 female) with all stages of B-type chronic lymphocytic leukemia (CLL) were studied for MDR1 phenotype using monoclonal antibodies and rhodamine-123 dye exclusion, a functional assay of MDR1 expression. The duration of the disease varied from 1 month to 22 years at the time of initial study. Overall, 74% of the patients were positive for rhodamine-123...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Antibodies, Monoclonal

Share to Antineoplastic Agents

Share to ATP Binding Cassette Transporter, Subfamily B, Member 1

Share to B-Lymphocytes

Share to Neoplasm Staging

Share to Phenotype

Source

Identifiers

PMID: 9671131
DOI: 10.1007/s002770050387

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differences in rhodamine-123 efflux in B-type chronic lymphocytic leukemia suggest possible gender and stage variations in drug-resistance gene activity.PMID 9671131Read ↗

Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.Semantic proximity Read ↗

Multidrug resistance activity in human lymphocytes.Semantic proximity Read ↗

Contrasting features of MDR phenotype in leukemias by using two fluorochromes: implications for clinical practice.Semantic proximity Read ↗

Staining with Hoechst 33342 and rhodamine 123: an attempt to detect multidrug resistant phenotype cells in leukemia.Semantic proximity Read ↗

Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.Semantic proximity Read ↗

A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.Semantic proximity Read ↗

Kinetic analysis of rhodamines efflux mediated by the multidrug resistance protein (MRP1).Semantic proximity Read ↗

Subclonal heterogeneity of the multidrug resistance phenotype in a cell line expressing antisense MDR1 RNA.Semantic proximity Read ↗

Retention of vital dyes correlates inversely with the multidrug-resistant phenotype of adriamycin-selected murine fibrosarcoma variants.Semantic proximity Read ↗

Functional study of multidrug resistance with fluorescent dyes. Limits of the assay for low levels of resistance and application in clinical samples.Semantic proximity Read ↗

Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability.Semantic proximity Read ↗

Flow cytometry evaluation of the multidrug-resistant phenotype with functional tests involving uptake of daunorubicin, Hoechst 33342, or rhodamine 123: a comparative study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.